Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-28

Clinical Trial Update: Comparative Efficacy of Rebamipide Gargle And Benzydamine HCL Gargle in Prevention and Management of Chemo- and Radio-therapy-induced Oral Mucositis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rebamipide gargle vs benzydamine HCl gargle for prevention and management of chemo- and radiotherapy-induced oral mucositis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • benzydamine HCl gargle (benzydamine hydrochloride)
  • rebamipide gargle (rebamipide)

Snippet

Sponsor: Cairo University | Conditions: Oral Mucositis | Phase 3 | Status: UNKNOWN